Armeniaspirol A: a novel anti‐Helicobacter pylori agent

Antibiotic resistance in Helicobacter pylori has been growing worldwide with current treatment regimens. Development of new compounds for treatment of H. pylori infections is urgently required to achieve a successful eradication therapy in the future. Armeniaspirols, a novel class of natural product...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Jia, Zhang, Chongwen, Liu, Yaqi, Huang, Yanqiang, Bai, Yuefan, Hang, Xudong, Zeng, Liping, Zhu, Dongqing, Bi, Hongkai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867979/
https://www.ncbi.nlm.nih.gov/pubmed/33780131
http://dx.doi.org/10.1111/1751-7915.13807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867979/
https://www.ncbi.nlm.nih.gov/pubmed/33780131
http://dx.doi.org/10.1111/1751-7915.13807

Ejemplares similares